$MGYR
Magyar Bancorp, Inc. Stock $mgyr

$mgyr Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000117494724000217 Filed on February 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$11.92M	$11.56M	$8.501M
YoY Change	29.93%	35.95%	21.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$223.0K	$217.0K	$208.0K
YoY Change	7.73%	4.33%	-0.48%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$4.997M	$4.313M	$1.610M
YoY Change	124.28%	167.89%	182.46%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$2.423M	$2.352M	$2.590M
YoY Change	-6.3%	-9.19%	9.42%
Income Tax	$526.0K	$700.0K	$780.0K
% Of Pretax Income	21.71%	29.76%	30.12%
Net Earnings	$1.897M	$1.652M	$1.810M
YoY Change	5.62%	-8.73%	6.91%
Net Earnings / Revenue	15.91%	14.29%	21.29%
Basic Earnings Per Share	$0.30	$0.26	$0.28
Diluted Earnings Per Share	$0.30	$0.26	$0.28
COMMON SHARES
Basic Shares Outstanding	6.654M shares	6.658M shares	6.743M shares
Diluted Shares Outstanding	6.372M shares	6.387M shares	6.459M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$49.99M	$51.12M	$7.878M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$12.44M	$12.53M	$13.68M
YoY Change	-8.59%	-8.4%	-23.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$928.6M	$916.7M	$821.6M
YoY Change	10.56%	11.58%	5.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.62M	$14.13M	$9.092M
YoY Change	-7.97%	55.44%	56.76%
Accrued Expenses			$3.440M
YoY Change			-16.1%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.62M	$14.13M	$12.53M
YoY Change	-7.97%	12.78%	26.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.62M	$14.13M	$12.53M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$820.9M	$810.2M	$721.7M
YoY Change	11.13%	12.26%	5.79%
SHAREHOLDERS EQUITY
Retained Earnings	$55.03M	$53.46M	$46.84M
YoY Change	13.56%	14.13%
Common Stock	$71.00K	$71.00K	$64.00M
YoY Change	-99.89%	-99.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$6.162M	$5.554M	$5.820M
YoY Change	-5.26%	-4.57%
Treasury Stock Shares			467.9K shares
Shareholders Equity	$107.6M	$106.5M	$99.92M
YoY Change
Total Liabilities & Shareholders Equity	$928.6M	$916.7M	$821.6M
YoY Change	10.56%	11.58%	5.24%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	$1.897M	$1.652M	$1.810M
YoY Change	5.62%	-8.73%	6.91%
Depreciation, Depletion And Amortization	$223.0K	$217.0K	$208.0K
YoY Change	7.73%	4.33%	-0.48%
Cash From Operating Activities	$553.0K	$3.224M	$1.335M
YoY Change	-80.77%	141.5%	-42.85%
INVESTING ACTIVITIES
Capital Expenditures	$125.0K	$128.0K	$10.00K
YoY Change	-3.85%	1180.0%	-112.5%
Acquisitions
YoY Change
Other Investing Activities	-$12.86M	-$31.21M	-$46.02M
YoY Change	11180.7%	-32.19%	26972.35%
Cash From Investing Activities	-$12.99M	-$31.34M	-$46.03M
YoY Change	5221.72%	-31.93%	18313.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$2.409M
YoY Change
Cash From Financing Activities	11.30M	$6.697M	$21.64M
YoY Change	-24.25%	-69.05%	334.19%
NET CHANGE
Cash From Operating Activities	553.0K	$3.224M	$1.335M
Cash From Investing Activities	-12.99M	-$31.34M	-$46.03M
Cash From Financing Activities	11.30M	$6.697M	$21.64M
Net Change In Cash	-1.128M	-$21.42M	-$23.06M
YoY Change	-106.43%	-7.13%	-426.14%
FREE CASH FLOW
Cash From Operating Activities	$553.0K	$3.224M	$1.335M
Capital Expenditures	$125.0K	$128.0K	$10.00K
Free Cash Flow	$428.0K	$3.096M	$1.325M
YoY Change	-84.41%	133.66%	-45.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity Registrant Name EntityRegistrantName	Magyar Bancorp, Inc.
CY2023Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-4154978
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 Somerset Street
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	New Brunswick
CY2023Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08901
CY2023Q4	dei	City Area Code CityAreaCode	(732)
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	342-7600
CY2023Q4	dei	Security12b Title Security12bTitle	Common Stock, $.01 per share
CY2023Q4	dei	Trading Symbol TradingSymbol	MGYR
CY2023Q4	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6653933	shares
CY2023Q4	us-gaap	Cash Cash	3128000	usd
CY2023Q3	us-gaap	Cash Cash	3179000	usd
CY2023Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	47989000	usd
CY2023Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	69353000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51117000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72532000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	12273000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	10125000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	75508000	usd
CY2023Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	73728000	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	84333000	usd
CY2023Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	85835000	usd
CY2023Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	2254000	usd
CY2023Q3	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	2286000	usd
CY2023Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	728560000	usd
CY2023Q3	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	697400000	usd
CY2023Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss Current DebtSecuritiesHeldToMaturityAllowanceForCreditLossCurrent	7683000	usd
CY2023Q3	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss Current DebtSecuritiesHeldToMaturityAllowanceForCreditLossCurrent	8330000	usd
CY2023Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	18126000	usd
CY2023Q3	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	18030000	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	4585000	usd
CY2023Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	4337000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12534000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13339000	usd
CY2023Q4	us-gaap	Other Real Estate OtherRealEstate	328000	usd
CY2023Q3	us-gaap	Other Real Estate OtherRealEstate	328000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	10312000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	11410000	usd
CY2023Q4	us-gaap	Assets Assets	916739000	usd
CY2023Q3	us-gaap	Assets Assets	907292000	usd
CY2023Q4	us-gaap	Deposits Deposits	763548000	usd
CY2023Q3	us-gaap	Deposits Deposits	755453000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	3723000	usd
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	3494000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	28796000	usd
CY2023Q3	us-gaap	Debt Current DebtCurrent	29515000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	656000	usd
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	443000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	13477000	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	13597000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	810200000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	802502000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7097825	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7097825	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6654952	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6674184	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	71000	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	71000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62962000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62801000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	442873	shares
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	423641	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	5554000	usd
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	5362000	usd
CY2023Q4	mgyr	Unearned Esop Shares Cost UnearnedEsopSharesCost	3047000	usd
CY2023Q3	mgyr	Unearned Esop Shares Cost UnearnedEsopSharesCost	3097000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	53456000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	52166000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1349000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1789000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	106539000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	104790000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	916739000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	907292000	usd
CY2023Q4	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	10082000	usd
CY2022Q4	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	7959000	usd
CY2023Q4	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	1406000	usd
CY2022Q4	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	504000	usd
CY2023Q4	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	14000	usd
CY2022Q4	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	14000	usd
CY2023Q4	mgyr	Federal Home Loan Bank Of New York Stock FederalHomeLoanBankOfNewYorkStock	55000	usd
CY2022Q4	mgyr	Federal Home Loan Bank Of New York Stock FederalHomeLoanBankOfNewYorkStock	24000	usd
CY2023Q4	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	11557000	usd
CY2022Q4	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	8501000	usd
CY2023Q4	us-gaap	Interest Expense Deposits InterestExpenseDeposits	4077000	usd
CY2022Q4	us-gaap	Interest Expense Deposits InterestExpenseDeposits	1474000	usd
CY2023Q4	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	236000	usd
CY2022Q4	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	136000	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	4313000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	1610000	usd
CY2023Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7244000	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6891000	usd
CY2023Q4	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	384000	usd
CY2022Q4	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	317000	usd
CY2023Q4	mgyr	Provision For Credit Losses Commitments ProvisionForCreditLossesCommitments	97000	usd
CY2023Q4	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	6763000	usd
CY2022Q4	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	6574000	usd
CY2023Q4	mgyr	Service Charge Income ServiceChargeIncome	303000	usd
CY2022Q4	mgyr	Service Charge Income ServiceChargeIncome	245000	usd
CY2023Q4	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	95000	usd
CY2022Q4	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	95000	usd
CY2022Q4	mgyr	Interest Rate Swap Fees InterestRateSwapFees	57000	usd
CY2023Q4	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	60000	usd
CY2023Q4	us-gaap	Other Operating Income OtherOperatingIncome	22000	usd
CY2022Q4	us-gaap	Other Operating Income OtherOperatingIncome	20000	usd
CY2023Q4	us-gaap	Gain Loss On Sale Of Loans And Leases GainLossOnSaleOfLoansAndLeases	129000	usd
CY2022Q4	us-gaap	Gain Loss On Sale Of Loans And Leases GainLossOnSaleOfLoansAndLeases	180000	usd
CY2023Q4	us-gaap	Noninterest Income NoninterestIncome	609000	usd
CY2022Q4	us-gaap	Noninterest Income NoninterestIncome	597000	usd
CY2023Q4	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2847000	usd
CY2022Q4	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2621000	usd
CY2023Q4	us-gaap	Occupancy Net OccupancyNet	790000	usd
CY2022Q4	us-gaap	Occupancy Net OccupancyNet	761000	usd
CY2023Q4	us-gaap	Professional Fees ProfessionalFees	226000	usd
CY2022Q4	us-gaap	Professional Fees ProfessionalFees	179000	usd
CY2023Q4	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	140000	usd
CY2022Q4	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	146000	usd
CY2023Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	224000	usd
CY2022Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	201000	usd
CY2023Q4	us-gaap	Business Development BusinessDevelopment	97000	usd
CY2022Q4	us-gaap	Business Development BusinessDevelopment	126000	usd
CY2023Q4	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	103000	usd
CY2022Q4	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	54000	usd
CY2023Q4	us-gaap	Other Noninterest Expense OtherNoninterestExpense	593000	usd
CY2022Q4	us-gaap	Other Noninterest Expense OtherNoninterestExpense	493000	usd
CY2023Q4	us-gaap	Noninterest Expense NoninterestExpense	5020000	usd
CY2022Q4	us-gaap	Noninterest Expense NoninterestExpense	4581000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2352000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2590000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	700000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	780000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	1652000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	1810000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6387010	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6456525	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6387010	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6459446	shares
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	1652000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	1810000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	584000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	206000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	584000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	206000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	144000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	50000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	440000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	156000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2092000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1966000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	104790000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	1652000	usd
CY2023Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
CY2023Q4	us-gaap	Dividends Common Stock DividendsCommonStock	716000	usd
CY2023Q4	mgyr	Effect Of Adopting Accounting Standards Update Two Thousand And Sixteen To Thirteen EffectOfAdoptingAccountingStandardsUpdateTwoThousandAndSixteenToThirteen	354000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	440000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	50000	usd
CY2023Q4	mgyr	Purchase Of Treasury Stock PurchaseOfTreasuryStock	192000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	161000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	106539000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	98502000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	1810000	usd
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
CY2022Q4	us-gaap	Dividends Common Stock DividendsCommonStock	744000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	156000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	41000	usd
CY2022Q4	mgyr	Purchase Of Treasury Stock PurchaseOfTreasuryStock	27000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	180000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	99918000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	1652000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	1810000	usd
CY2023Q4	us-gaap	Depreciation Depreciation	217000	usd
CY2022Q4	us-gaap	Depreciation Depreciation	208000	usd
CY2023Q4	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-20000	usd
CY2022Q4	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-43000	usd
CY2023Q4	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	481000	usd
CY2022Q4	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	317000	usd
CY2023Q4	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	1613000	usd
CY2022Q4	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	1825000	usd
CY2023Q4	mgyr	Proceeds From Sales Of Loans Receivable ProceedsFromSalesOfLoansReceivable	1741000	usd
CY2022Q4	mgyr	Proceeds From Sales Of Loans Receivable ProceedsFromSalesOfLoansReceivable	2005000	usd
CY2023Q4	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	129000	usd
CY2022Q4	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	180000	usd
CY2023Q4	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	60000	usd
CY2023Q4	mgyr	Esop Compensation Expense EsopCompensationExpense	50000	usd
CY2022Q4	mgyr	Esop Compensation Expense EsopCompensationExpense	41000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	161000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	180000	usd
CY2023Q4	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	221000	usd
CY2022Q4	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-237000	usd
CY2023Q4	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	248000	usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	348000	usd
CY2023Q4	mgyr	Increase In Surrender Value Bank Owned Life Insurance IncreaseInSurrenderValueBankOwnedLifeInsurance	95000	usd
CY2022Q4	mgyr	Increase In Surrender Value Bank Owned Life Insurance IncreaseInSurrenderValueBankOwnedLifeInsurance	95000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-733000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-160000	usd
CY2023Q4	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	213000	usd
CY2022Q4	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	77000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-120000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-821000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3224000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1335000	usd
CY2023Q4	mgyr	Net Increase Decrease In Loans Receivable NetIncreaseDecreaseInLoansReceivable	-31934000	usd
CY2022Q4	mgyr	Net Increase Decrease In Loans Receivable NetIncreaseDecreaseInLoansReceivable	-46554000	usd
CY2023Q4	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	2000000	usd
CY2023Q4	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1953000	usd
CY2023Q4	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	3487000	usd
CY2022Q4	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	992000	usd
CY2023Q4	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	384000	usd
CY2022Q4	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	209000	usd
CY2023Q4	mgyr	Sales Of Payments For Property And Equipment SalesOfPaymentsForPropertyAndEquipment	128000	usd
CY2022Q4	mgyr	Sales Of Payments For Property And Equipment SalesOfPaymentsForPropertyAndEquipment	10000	usd
CY2023Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	776000	usd
CY2022Q4	mgyr	Investment In Other Real Estate InvestmentInOtherRealEstate	11000	usd
CY2023Q4	us-gaap	Payments To Acquire Federal Home Loan Bank Stock PaymentsToAcquireFederalHomeLoanBankStock	76000	usd
CY2022Q4	us-gaap	Payments To Acquire Federal Home Loan Bank Stock PaymentsToAcquireFederalHomeLoanBankStock	2582000	usd
CY2023Q4	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	108000	usd
CY2022Q4	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	1923000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31336000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-46033000	usd
CY2023Q4	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	8095000	usd
CY2022Q4	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	8350000	usd
CY2023Q4	mgyr	Net Increase In Escrowed Funds NetIncreaseInEscrowedFunds	229000	usd
CY2022Q4	mgyr	Net Increase In Escrowed Funds NetIncreaseInEscrowedFunds	-39000	usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1690000	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3000000	usd
CY2023Q4	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2409000	usd
CY2022Q4	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	11100000	usd
CY2023Q4	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	716000	usd
CY2022Q4	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	744000	usd
CY2023Q4	mgyr	Purchase Treasury Stock PurchaseTreasuryStock	192000	usd
CY2022Q4	mgyr	Purchase Treasury Stock PurchaseTreasuryStock	27000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6697000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21640000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21415000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-23058000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72532000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30936000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51117000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7878000	usd
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet	4100000	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	1533000	usd
CY2023Q4	mgyr	Adoption Of Accounting Standards Update AdoptionOfAccountingStandardsUpdate	354000	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	11.51
CY2023Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	217084	shares
CY2023Q4	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	492000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	346000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	4300000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	1652000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	1810000	usd
CY2023Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	337146	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	442873	shares
CY2021	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	312800	shares
CY2021	us-gaap	Stock Issued1 StockIssued1	3400000	usd
CY2021Q3	us-gaap	Share Price SharePrice	10.77
CY2021Q3	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.0325	pure
CY2021Q3	mgyr	Principal And Interest Payable Term PrincipalAndInterestPayableTerm	P30Y
CY2023Q3	us-gaap	Shares Held In Employee Stock Option Plan Allocated SharesHeldInEmployeeStockOptionPlanAllocated	170335	shares
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6387010	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6456525	shares
CY2022Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2921	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6387010	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6459446	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	293200	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.58
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	12.63
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	293200	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.58
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	12.63
CY2022Q3	mgyr	Equity Compensation Shares EquityCompensationShares	547400	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	293200	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	293200	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.58
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y11M23D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	293200	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.58
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P8Y8M23D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	58640	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.58
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y8M23D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	124320	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	12.63
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	124320	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	12.63
CY2023Q4	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	63000	usd
CY2023Q4	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	98000	usd
CY2022Q4	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	69000	usd
CY2022Q4	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	111000	usd
CY2023Q4	mgyr	Unvested Stock Options And Stock Awards UnvestedStockOptionsAndStockAwards	2400000	usd
CY2022Q4	mgyr	Percentage Of Repurchase Additional PercentageOfRepurchaseAdditional	0.05	pure
CY2022Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	120062	shares
CY2023Q3	us-gaap	Shares Held In Employee Stock Option Plan Suspense Shares SharesHeldInEmployeeStockOptionPlanSuspenseShares	290313	shares
CY2023Q3	us-gaap	Derivative Net Liability Position Aggregate Fair Value DerivativeNetLiabilityPositionAggregateFairValue	3300000	usd
CY2023Q4	us-gaap	Contribution Of Property ContributionOfProperty	50000	usd
CY2022Q4	us-gaap	Contribution Of Property ContributionOfProperty	41000	usd
CY2023Q4	mgyr	Unrealized Gain Loss On Available For Sale Securities UnrealizedGainLossOnAvailableForSaleSecurities	584000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	144000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	440000	usd
CY2022Q4	mgyr	Unrealized Gain Loss On Available For Sale Securities UnrealizedGainLossOnAvailableForSaleSecurities	206000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	50000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	156000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	584000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	144000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	440000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	206000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	50000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	156000	usd
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	12273000	usd
CY2023Q4	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	1961000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	14234000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1961000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1961000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	10125000	usd
CY2023Q3	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	2579000	usd
CY2023Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	12704000	usd
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	2579000	usd
CY2023Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	2579000	usd
CY2023Q4	mgyr	Loans Receivable Gross Carrying Amount LoansReceivableGrossCarryingAmount	729494000	usd
CY2023Q4	mgyr	Pledged Asset Separately Reported Securities Pledged For Repurchase Agreements At Fair Value PledgedAssetSeparatelyReportedSecuritiesPledgedForRepurchaseAgreementsAtFairValue	12200000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	9903000	usd
CY2023Q4	mgyr	Investment Securities Gross Unrealized Losses InvestmentSecuritiesGrossUnrealizedLosses	1420000	usd
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	83637000	usd
CY2023Q3	mgyr	Investment Securities Gross Unrealized Losses InvestmentSecuritiesGrossUnrealizedLosses	14072000	usd
CY2023Q3	mgyr	Loans Receivable Gross Carrying Amount LoansReceivableGrossCarryingAmount	698206000	usd
CY2023Q4	mgyr	Loans And Leases Receivable Deferred Cost LoansAndLeasesReceivableDeferredCost	-934000	usd
CY2023Q3	mgyr	Loans And Leases Receivable Deferred Cost LoansAndLeasesReceivableDeferredCost	-806000	usd
CY2023Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	728560000	usd
CY2023Q3	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	697400000	usd
CY2023Q4	mgyr	Commercial Relationships Description CommercialRelationshipsDescription	Generally, the external consultant reviews commercial relationships greater than $500,000 and/or criticized relationships greater than $250,000.
CY2023Q3	mgyr	Loans Receivable Gross Carrying Amount LoansReceivableGrossCarryingAmount	698206000	usd
CY2023Q4	mgyr	Loans Receivable Current LoansReceivableCurrent	721904000	usd
CY2023Q4	mgyr	Loans Receivable Past Due LoansReceivablePastDue	729494000	usd
CY2023Q3	mgyr	Loans Receivable Current LoansReceivableCurrent	692291000	usd
CY2023Q3	mgyr	Loans Receivable Past Due LoansReceivablePastDue	698206000	usd
CY2023Q4	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	152000	usd
CY2023Q4	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	2225000	usd
CY2023Q4	mgyr	Interest And Fee Income Loans Commercial Land InterestAndFeeIncomeLoansCommercialLand	2474000	usd
CY2023Q4	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	4851000	usd
CY2023Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	7621000	usd
CY2023Q3	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	7621000	usd
CY2023Q3	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	7686000	usd
CY2023Q4	mgyr	Impaired Loans And Interest Income ImpairedLoansAndInterestIncome	5754000	usd
CY2023Q4	mgyr	Interest Income Recognized On An Accrual Basis On Impaired Loans InterestIncomeRecognizedOnAnAccrualBasisOnImpairedLoans	35000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8330000	usd
CY2023Q4	mgyr	Effect Of Adopting EffectOfAdopting	-1032000	usd
CY2023Q4	us-gaap	Provision For Other Losses ProvisionForOtherLosses	385000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	7683000	usd
CY2022Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8433000	usd
CY2022Q4	us-gaap	Provision For Other Losses ProvisionForOtherLosses	317000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8750000	usd
CY2022Q4	mgyr	Number Of Loans NumberOfLoans	1	pure
CY2022Q4	mgyr	Investment Before Tdr Modification InvestmentBeforeTDRModification	97000	usd
CY2022Q4	mgyr	Investment After Tdr Modification InvestmentAfterTDRModification	107000	usd
CY2023Q4	us-gaap	Demand Deposit Accounts DemandDepositAccounts	164453000	usd
CY2023Q3	us-gaap	Demand Deposit Accounts DemandDepositAccounts	188550000	usd
CY2023Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	60008000	usd
CY2023Q3	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	62168000	usd
CY2023Q4	us-gaap	Deposits Negotiable Order Of Withdrawal Now DepositsNegotiableOrderOfWithdrawalNOW	119738000	usd
CY2023Q3	us-gaap	Deposits Negotiable Order Of Withdrawal Now DepositsNegotiableOrderOfWithdrawalNOW	115182000	usd
CY2023Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	306886000	usd
CY2023Q3	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	284885000	usd
CY2023Q4	mgyr	Certificates Of Deposit CertificatesOfDeposit	100547000	usd
CY2023Q3	mgyr	Certificates Of Deposit CertificatesOfDeposit	92725000	usd
CY2023Q4	mgyr	Retirement Deposits RetirementDeposits	11916000	usd
CY2023Q3	mgyr	Retirement Deposits RetirementDeposits	11943000	usd
CY2023Q4	us-gaap	Deposits Deposits	763548000	usd
CY2023Q3	us-gaap	Deposits Deposits	755453000	usd
CY2023Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	15500000	usd
CY2023Q3	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	13800000	usd
CY2023Q4	mgyr	Fdic Insuranc Bank Deposits FDICInsurancBankDeposits	250000	usd
CY2023Q3	mgyr	Fdic Insuranc Bank Deposits FDICInsurancBankDeposits	250000	usd
CY2023Q3	mgyr	Large Deposits LargeDeposits	429900000	usd
CY2023Q4	us-gaap	Collateralized Financings CollateralizedFinancings	120200000	usd
CY2023Q3	us-gaap	Collateralized Financings CollateralizedFinancings	109300000	usd
CY2023Q4	mgyr	Financial Instruments Contract Amounts FinancialInstrumentsContractAmounts	117010000	usd
CY2023Q3	mgyr	Financial Instruments Contract Amounts FinancialInstrumentsContractAmounts	121056000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	540000	usd
CY2023Q4	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	637000	usd
CY2023Q3	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	0	usd
CY2022Q4	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022Q4	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities		usd
CY2022Q4	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt		usd
CY2022Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities		usd
CY2023Q4	mgyr	Investment In Other Real Estate InvestmentInOtherRealEstate		usd
CY2022Q4	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2023Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q4	mgyr	Adoption Of Accounting Standards Update AdoptionOfAccountingStandardsUpdate		usd
CY2023Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q4	mgyr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
CY2023Q4	mgyr	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValueGranted		usd
CY2023Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	mgyr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q4	mgyr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm
CY2023Q4	mgyr	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeiture In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureInPeriodTotalIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q4	mgyr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Expired Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpiredWeightedAverageRemainingContractualTerm
CY2023Q4	mgyr	Sharebased Compensation Arrangement By Sharebased Payment Expired Aggregate Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentExpiredAggregateIntrinsicValue		usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares		shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares		shares
CY2023Q3	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment		usd
CY2023Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance		usd
CY2023Q4	mgyr	Chargeoffs Chargeoffs		usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery		usd
CY2022Q4	mgyr	Chargeoffs Chargeoffs		usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery		usd
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001337068

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001174947-24-000217-index-headers.html	Edgar Link	pending
0001174947-24-000217-index.html	Edgar Link	pending
0001174947-24-000217.txt	Edgar Link	pending
0001174947-24-000217-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mgyr-20231231.htm	Edgar Link	pending
mgyr-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
mgyr-20231231_cal.xml	Edgar Link	unprocessable
mgyr-20231231_def.xml	Edgar Link	unprocessable
mgyr-20231231_lab.xml	Edgar Link	unprocessable
mgyr-20231231_pre.xml	Edgar Link	unprocessable
mgyr-20231231_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MGYR
Magyar Bancorp, Inc. Stock $mgyr

2024 Q1 Form 10-Q Financial Statement

#000117494724000217 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGYR Magyar Bancorp, Inc. Stock $mgyr

2024 Q1 Form 10-Q Financial Statement

#000117494724000217 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGYR
Magyar Bancorp, Inc. Stock $mgyr